Delivery to the Brain via Nasal Cavity Without Surgery
Faster Functional Recovery Demonstrated in Animal Experiments

A new possibility has been proposed for treating traumatic brain injury, which occurs due to accidents or trauma, without surgery—by delivering stem cells through the nasal cavity.

Professor Chanheum Park, Department of Otorhinolaryngology, Hallym University Chuncheon Sacred Heart Hospital. Hallym University Chuncheon Sacred Heart Hospital

Professor Chanheum Park, Department of Otorhinolaryngology, Hallym University Chuncheon Sacred Heart Hospital. Hallym University Chuncheon Sacred Heart Hospital

View original image

On March 13, Hallym University Chuncheon Sacred Heart Hospital announced that a research team led by Professor Chanheum Park of the Department of Otorhinolaryngology has developed a non-invasive treatment strategy that delivers stem cells to the brain via the nasal cavity and confirmed its therapeutic effects in animal experiments.


Traumatic brain injury is a severe condition in which nerve cells are damaged or die due to a strong impact, leading to impaired cognitive and motor functions. Although research on stem cell therapy is ongoing, most approaches require direct injection of cells into brain tissue, which carries a high surgical burden and results in low cell survival rates.


The research team focused on the “nasal delivery pathway,” through which drugs or cells can reach the brain via the inner nasal mucosa. They mass-cultured stem cells in a bioreactor, formed them into neurospheres, and then encapsulated them in a silk protein-based hydrogel for delivery through the nasal cavity. The hydrogel encapsulation technology protects the stem cells, increases their survival rate in the body, and helps various therapeutic factors secreted by the cells reach the site of brain injury.


The research team evaluated the therapeutic effects in an animal model of traumatic brain injury. The group that received the stem cell neurospheres began to recover function approximately three days after treatment, and after one week, their recovery rate was about twice as fast as the group that did not receive treatment.


In the brain regions responsible for memory and learning, levels of recovery-related proteins, which had decreased after injury, were restored to near-normal levels. The accumulation of toxic substances and oxidative stress in the damaged brain tissue was also reduced, and the structure of connections between nerve cells remained stably maintained.


The production system for the stem cell therapy was also verified. Using a bioreactor-based culture system, the team was able to mass-produce mesenchymal stem cells and establish a “Master Cell Bank” to store them. This enabled the repeated production of cells with identical properties and provided a stable supply of therapeutic cells as needed.



Professor Park stated, “Delivering stem cells via the nasal cavity is a strategy that enables repeated treatments without brain surgery.” He added, “This study not only confirms the potential for treating traumatic brain injury, but also for expanding applications to various neurological diseases such as Parkinson’s disease and Alzheimer’s disease.” He continued, “We plan to further verify the therapeutic effects and safety through additional improvements and follow-up studies in the future.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing